ERNA vs PLTR · P/E 0.0, rev $582.0K vs P/E 584, rev $4.48B
Eterna Therapeutics Inc (ERNA) versus Palantir Technologies Inc. Class A Common Stock (PLTR) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Palantir Technologies Inc. Class A Common Stock (PLTR) is a software - infrastructure company listed on US. It is led by Alex Karp.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported PLTR revenue for 2025-12-31 was $4.48B. Net income was $1.63B. Revenue was up 56.2% from 2024-12-31 to 2025-12-31. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
Not investment advice. Open the ERNA and PLTR stock pages for the full models.
Not investment advice.